Cathy O'Hare is an experienced professional in the field of biomarkers and diagnostics, currently serving as Head of Operations at NewLimit since October 2024. Previously, Cathy held roles at GSK, including Medicine Development Leader and Sr. Clinical Development Director, where responsibilities included leading late-stage clinical assets and developing strategic clinical plans. Cathy has expertise in managing preclinical research and implementing biomarker strategies, with significant contributions in both oncology and non-oncology programs across various organizations, including Medivation and the University of Cambridge. Academic training includes a PhD from the University of California, San Francisco, solidifying a foundation in advanced research methodologies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices